Novel non-canonical TGF-β signaling networks: Emerging roles in airway smooth muscle phenotype and function

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 50-63

  Yeganeh, Behzad ^a   Mukherjee, Subhendu ^e   Moir, Lyn M ^c,d   Kumawat, Kuldeep ^b   Kashani, Hessam H ^a   Bagchi, Rushita A ^a   Baarsma, Hoeke A ^b   Gosens, Reinoud ^b   Ghavami, Saeid ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Asthma; Autophagy; Calcium; Chronic obstructive pulmonary disease; HMGB1; PI3K signaling; S100 proteins; WNT catenin signaling

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 9 (1 ANILINOETHYL) 7 METHYL 2 MORPHOLINOPYRIDO[1,2 A]PYRIMIDIN 4 ONE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; CALCIUM ION; CALPONIN; CHEMOKINE; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; FIBRONECTIN; LYMPHOID ENHANCER FACTOR 1; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NIFEDIPINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PIK 75; PROTEIN P70; PROTEOGLYCAN; RYANODINE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT PROTEIN;

AIRWAY REMODELING; ARTICLE; ASTHMA; AUTOCRINE EFFECT; AUTOPHAGY; BREATHING MUSCLE; CATALYSIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; EOSINOPHILIA; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYPERTROPHY; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MUSCLE FUNCTION; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; XENOPUS;

ANIMALS; ASTHMA; CHEMOKINES; CYTOKINES; HUMANS; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873157043     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.07.006     Document Type: Article

References (187)

1. Branton M.H., Kopp J.B. TGF-beta and fibrosis. Microbes Infect 1999, 1:1349-1365.
2. Roulot D., Sevcsik A.M., Coste T., Strosberg A.D., Marullo S. Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 1999, 29:1730-1738.
3. Janssens K., Ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 2005, 26:743-774.
4. Poon A.H., Chouiali F., Tse S.M., Litonjua A.A., Hussain S.N., Baglole C.J., et al. Genetic and histologic evidence for autophagy in asthma pathogenesis. J Allergy Clin Immunol 2012, 129:569-571.
5. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 1988, 8:4162-4168.
6. Ribeiro S.M., Poczatek M., Schultz-Cherry S., Villain M., Murphy-Ullrich J.E. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999, 274:13586-13593.
7. Morris D.G., Huang X., Kaminski N., Wang Y., Shapiro S.D., Dolganov G., et al. Loss of integrin alpha(V)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003, 422:169-173.
8. Prime S.S., Pring M., Davies M., Paterson I.C. TGF-beta signal transduction in oro-facial health and non-malignant disease (Part I). Crit Rev Oral Biol Med 2004, 15:324-336.
9. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev 2004, 15:1-11.
10. Piek E., Heldin C.H., Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999, 13:2105-2124.
11. Edlund S., Landstrom M., Heldin C.H., Aspenstrom P. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small Gtpases Cdc42 and Rhoa. Mol Biol Cell 2002, 13:902-914.
12. Runyan C.E., Schnaper H.W., Poncelet A.C. Smad3 and Pkcdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Ren Physiol 2003, 285:F413-F422.
13. Higaki M., Shimokado K. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999, 19:2127-2132.
14. Atfi A., Djelloul S., Chastre E., Davis R., Gespach C. Evidence for a role of rho-like Gtpases and stress-activated protein kinase/C-Jun N-terminal kinase (Sapk/Jnk) in transforming growth factor beta-mediated signaling. J Biol Chem 1997, 272:1429-1432.
15. Hannigan M., Zhan L., Ai Y., Huang C.K. The role of P38 map kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 1998, 246:55-58.
16. Baarsma H.A., Menzen M.H., Halayko A.J., Meurs H., Kerstjens H.A., Gosens R. Beta-catenin signaling is required for TGF-beta1-induced extracellular matrix production by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011, 301:L956-L965.
17. Hirota M., Watanabe K., Hamada S., Sun Y., Strizzi L., Mancino M., et al. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of P300. Cell Signal 2008, 20:1632-1641.
18. Santibanez J.F., Quintanilla M., Bernabeu C. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011, 121:233-251.
19. Camoretti-Mercado B., Solway J. Transforming growth factor-beta1 and disorders of the lung. Cell Biochem Biophys 2005, 43:131-148.
20. Howell J.E., McAnulty R.J. TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006, 7:547-565.
21. Koli K., Myllarniemi M., Keski-Oja J., Kinnula V.L. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008, 10:333-342.
22. Moore B., Murphy R.F., Agrawal D.K. Interaction of TGF-beta with immune cells in airway disease. Curr Mol Med 2008, 8:427-436.
23. Wells R.G., Fibrogenesis V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 2000, 279:G845-G850.
24. Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., et al. Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 2012, 3:735.
25. Schaafsma D., McNeill K.D., Mutawe M.M., Ghavami S., Unruh H., Jacques E., et al. Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts. Resp Res 2011, 12:113.
26. Ye H., Cai P.C., Zhou Q., Ma W.L. Transforming growth factor-beta1 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis factor-alpha. Wound Repair Regen 2011, 19:392-399.
27. Heino J., Ignotz R.A., Hemler M.E., Crouse C., Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 1989, 264:380-388.
28. Moir L.M., Burgess J.K., Black J.L. Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle. J Allergy Clin Immunol 2008, 121:1034-1039. e4.
29. Morty R.E., Konigshoff M., Eickelberg O. Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009, 6:607-613.
30. Lee C.G., Kang H.R., Homer R.J., Chupp G., Elias J.A. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 2006, 3:418-423.
31. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
32. Le Saux C.J., Teeters K., Miyasato S.K., Hoffmann P.R., Bollt O., Douet V., et al. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J Biol Chem 2008, 283:5760-5768.
33. Postma D.S., Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:434-439.
34. Halayko A.J., Tran T., Ji S.Y., Yamasaki A., Gosens R. Airway smooth muscle phenotype and function: interactions with current asthma therapies. Curr Drug Targets 2006, 7:525-540.
35. Torrego A., Hew M., Oates T., Sukkar M., Fan Chung K. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007, 62:307-313.
36. Bottoms S.E., Howell J.E., Reinhardt A.K., Evans I.C., McAnulty R.J. TGF-beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS One 2010, 5:e9674.
37. Redington A.E., Roche W.R., Holgate S.T., Howarth P.H. Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects. J Pathol 1998, 186:410-415.
38. Minshall E.M., Leung D.Y., Martin R.J., Song Y.L., Cameron L., Ernst P., et al. Eosinophil-associated TGF-Beta1 Mrna expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326-333.
39. Halwani R., Al-Muhsen S., Al-Jahdali H., Hamid Q. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol 2011, 44:127-133.
40. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 2004, 305:1776-1779.
41. Bottema R.W., Kerkhof M., Reijmerink N.E., Thijs C., Smit H.A., van Schayck C.P., et al. Gene-gene interaction in regulatory T-cell function in atopy and asthma development in childhood. J Allergy Clin Immunol 2010, 126:338-346. 46 e1-10.
42. Zhang Y., Zhang J., Huang J., Li X., He C., Tian C., et al. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: a meta-analysis. Respirology 2010, 15:643-650.
43. de Medeiros Matsushita M., da Silva L.F., dos Santos M.A., Fernezlian S., Schrumpf J.A., Roughley P., et al. Airway proteoglycans are differentially altered in fatal asthma. J Pathol 2005, 207:102-110.
44. Halayko A.J., Amrani Y. Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol 2003, 137:209-222.
45. Holgate S.T. The bronchial epithelial origins of asthma. Chem Immunol 2000, 78:62-71.
46. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720-1745.
47. Hoshino M., Nakamura Y., Hamid Q.A. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001, 107:1034-1038.
48. Rogers D.F. Airway mucus hypersecretion in asthma: an undervalued pathology?. Curr Opin Pharmacol 2004, 4:241-250.
49. Michalik M., Pierzchalska M., Legutko A., Ura M., Ostaszewska A., Soja J., et al. Asthmatic bronchial fibroblasts demonstrate enhanced potential to differentiate into myofibroblasts in culture. Med Sci Monit 2009, 15:BR194-BR201.
50. Beasley M.B. Smoking-related small airway disease-a review and update. Adv Anat Pathol 2010, 17:270-276.
51. Churg A., Tai H., Coulthard T., Wang R., Wright J.L. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006, 174:1327-1334.
52. van Diemen C.C., Postma D.S., Vonk J.M., Bruinenberg M., Nolte I.M., Boezen H.M. Decorin and TGF-beta1 polymorphisms and development of copd in a general population. Resp Res 2006, 7:89.
53. Soler Artigas M., Loth D.W., Wain L.V., Gharib S.A., Obeidat M., Tang W., et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011, 43:1082-1090.
54. Takizawa H., Tanaka M., Takami K., Ohtoshi T., Ito K., Satoh M., et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (copd). Am J Respir Crit Care Med 2001, 163:1476-1483.
55. de Boer W.I., van Schadewijk A., Sont J.K., Sharma H.S., Stolk J., Hiemstra P.S., et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:1951-1957.
56. Zandvoort A., Postma D.S., Jonker M.R., Noordhoek J.A., Vos J.T., Timens W. Smad gene expression in pulmonary fibroblasts: indications for defective Ecm repair in Copd. Resp Res 2008, 9:83.
57. Andersson-Sjoland A., Thiman L., Nihlberg K., Hallgren O., Rolandsson S., Skog I., et al. Fibroblast phenotypes and their activity are changed in the wound healing process after lung transplantation. J Heart Lung Transplant 2011, 30:945-954.
58. Hallgren O., Nihlberg K., Dahlback M., Bjermer L., Eriksson L.T., Erjefalt J.S., et al. Altered fibroblast proteoglycan production in Copd. Resp Res 2010, 11:55.
59. Wang H., Liu X., Umino T., Kohyama T., Zhu Y.K., Wen F.Q., et al. Effect of cigarette smoke on fibroblast-mediated gel contraction is dependent on cell density. Am J Physiol Lung Cell Mol Physiol 2003, 284:L205-L213.
60. Krimmer D.I., Burgess J.K., Wooi T.K., Black J.L., Oliver B.G. Matrix proteins from smoke-exposed fibroblasts are pro-proliferative. Am J Respir Cell Mol Biol 2012, 46:34-39.
61. Springer J., Scholz F.R., Peiser C., Groneberg D.A., Fischer A. Smad-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory Smad 6 and 7 by cigarette smoke. Biol Chem 2004, 385:649-653.
62. Yi J.Y., Shin I., Arteaga C.L. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-Kinase. J Biol Chem 2005, 280:10870-10876.
63. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001, 70:535-602.
64. Burgess J.K., Lee J.H., Ge Q., Ramsay E.E., Poniris M.H., Parmentier J., et al. Dual Erk and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma. J Cell Physiol 2008, 216:673-679.
65. Day R.M., Lee Y.H., Park A.M., Suzuki Y.J. Retinoic acid inhibits airway smooth muscle cell migration. Am J Respir Cell Mol Biol 2006, 34:695-703.
66. Lee I.T., Lee C.W., Tung W.H., Wang S.W., Lin C.C., Shu J.C., et al. Cooperation of Tlr2 with Myd88, Pi3k, and Rac1 in lipoteichoic acid-induced Cpla2/Cox-2-dependent airway inflammatory responses. Am J Pathol 2010, 176:1671-1684.
67. Ma L., Brown M., Kogut P., Serban K., Li X., McConville J., et al. Akt activation induces hypertrophy without contractile phenotypic maturation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2011, 300:L701-L709.
68. Sun X., Yasuda O., Takemura Y., Kawamoto H., Higuchi M., Baba Y., et al. Akt activation prevents Apop-1-induced death of cells. Biochem Biophys Res Commun 2008, 377:1097-1101.
69. Vantler M., Caglayan E., Zimmermann W.H., Baumer A.T., Rosenkranz S. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important. J Biol Chem 2005, 280:14168-14176.
70. Krymskaya V.P., Penn R.B., Orsini M.J., Scott P.H., Plevin R.J., Walker T.R., et al. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. Am J Physiol 1999, 277:L65-L78.
71. Moir L.M., Trian T., Ge Q., Shepherd P.R., Burgess J.K., Oliver B.G., et al. Phosphatidylinositol 3-kinase isoform-specific effects in airway mesenchymal cell function. J Pharmacol Exp Ther 2011, 337:557-566.
72. Ito K., Caramori G., Adcock I.M. Therapeutic potential of phosphatidylinositol 3-Kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 2007, 321:1-8.
73. Farghaly H.S., Blagbrough I.S., Medina-Tato D.A., Watson M.L. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-Kinase P110delta-dependent mechanism. Mol Pharmacol 2008, 73:1530-1537.
74. Schaafsma D., McNeill K.D., Stelmack G.L., Gosens R., Baarsma H.A., Dekkers B.G., et al. Insulin increases the expression of contractile phenotypic markers in airway smooth muscle. Am J Physiol Cell Physiol 2007, 293:C429-C439.
75. Halayko A.J., Kartha S., Stelmack G.L., McConville J., Tam J., Camoretti-Mercado B., et al. Phophatidylinositol-3 kinase/mammalian target of rapamycin/P70s6k regulates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 2004, 31:266-275.
76. Goldsmith A.M., Bentley J.K., Zhou L., Jia Y., Bitar K.N., Fingar D.C., et al. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 2006, 34:247-254.
77. Xia Y.C., Redhu N.S., Moir L.M., Koziol-White C., Ammit A.J., Al-Alwan L., et al. Pro-Inflammatory and immunomodulatory functions of airway smooth muscle: emerging concepts. Pulm Pharmacology Therapeutics 2012.
78. Michaeloudes C., Sukkar M.B., Khorasani N.M., Bhavsar P.K., Chung K.F. TGF-beta regulates Nox4, Mnsod and catalase expression, and Il-6 release in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011, 300:L295-L304.
79. Shin J.H., Shim J.W., Kim D.S., Shim J.Y. TGF-beta effects on airway smooth muscle cell proliferation, Vegf release and signal transduction pathways. Respirology 2009, 14:347-353.
80. Roche W.R., Beasley R., Williams J.H., Holgate S.T. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
81. Burgess J.K., Johnson P.R., Ge Q., Au W.W., Poniris M.H., McParland B.E., et al. Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 2003, 167:71-77.
82. Johnson P.R., Burgess J.K., Ge Q., Poniris M., Boustany S., Twigg S.M., et al. Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. Am J Respir Crit Care Med 2006, 173:32-41.
83. Chaussade C., Rewcastle G.W., Kendall J.D., Denny W.A., Cho K., Gronning L.M., et al. Evidence for functional redundancy of class Ia Pi3k isoforms in insulin signalling. The Biochem J 2007, 404:449-458.
84. Bi L., Okabe I., Bernard D.J., Wynshaw-Boris A., Nussbaum R.L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the P110α subunit of phosphoinositide 3-kinase. J Biol Chem 1999, 274:10963-10968.
85. Lee K.S., Lee H.K., Hayflick J.S., Lee Y.C., Puri K.D. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 2006, 20:455-465.
86. Nusse R. Wnt signaling in disease and in development. Cell Res 2005, 15:28-32.
87. Kikuchi A., Yamamoto H., Sato A., Matsumoto S. New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 2011, 291:21-71.
88. Watanabe K., Dai X. A Wnter revisit: new faces of beta-catenin and Tcfs in pluripotency. Sci Signal 2011, 4:pe41.
89. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
90. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009, 10:468-477.
91. Chang H., Brown C.W., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev 2002, 23:787-823.
92. Nishita M., Hashimoto M.K., Ogata S., Laurent M.N., Ueno N., Shibuya H., et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000, 403:781-785.
93. Labbe E., Letamendia A., Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and Wnt pathways. Proc Natl Acad Sci U S A 2000, 97:8358-8363.
94. Clifford R.L., Deacon K., Knox A.J. Novel regulation of vascular endothelial growth factor-a (Vegf-a) by Transforming growth factor (Beta)1: requirement for Smads, (beta)-catenin, and Gsk3(beta). J Biol Chem 2008, 283:35337-35353.
95. Lei S., Dubeykovskiy A., Chakladar A., Wojtukiewicz L., Wang T.C. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways. J Biol Chem 2004, 279:42492-42502.
96. Cheon S.S., Nadesan P., Poon R., Alman B.A. Growth factors regulate beta-catenin-mediated Tcf-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res 2004, 293:267-274.
97. Baarsma H.A., Spanjer A.I., Haitsma G., Engelbertink L.H., Meurs H., Jonker M.R., et al. Activation of Wnt/beta-catenin signaling in pulmonary fibroblasts by TGF-beta is increased in chronic obstructive pulmonary disease. PLoS One 2011, 6:e25450.
98. Gosens R., Baarsma H.A., Heijink I.H., Oenema T.A., Halayko A.J., Meurs H., et al. De novo synthesis of {beta}-catenin via H-Ras and Mek regulates airway smooth muscle growth. FASEB J 2010, 24:757-768.
99. Zhang M., Wang M., Tan X., Li T.F., Zhang Y.E., Chen D. Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem 2010, 285:8703-8710.
100. Carthy J.M., Garmaroudi F.S., Luo Z., McManus B.M. Wnt3a induces myofibroblast differentiation by upregulating TGF-beta signaling through Smad2 in a beta-catenin-dependent manner. PLoS One 2011, 6:e19809.
101. Kumawat K., Bos S., Borger P., Tamm M., Postma D.S., Koppelman G.H., et al. Autocrine Wnt5a signaling is increased in asthma and regulates TGF-beta1 induced Ecm production by airway smooth muscle cells. Am J Respir Crit Care Med 2011, 183.
102. Gosens R., Meurs H., Schmidt M. The Gsk-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:185-191.
103. Dekkers B.G., Maarsingh H., Meurs H., Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc 2009, 6:683-692.
104. Deng H., Dokshin G.A., Lei J., Goldsmith A.M., Bitar K.N., Fingar D.C., et al. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy. J Biol Chem 2008, 283:10198-10207.
105. Jansen S.R., Van Ziel A.M., Baarsma H.A., Gosens R. {Beta}-catenin regulates airway smooth muscle contraction. Am J Physiol Lung Cell Mol Physiol 2010, 299:L204-L214.
106. Nunes R.O., Schmidt M., Dueck G., Baarsma H., Halayko A.J., Kerstjens H.A., et al. Gsk-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1110-L1118.
107. Rodland K.D., Muldoon L.L., Magun B.E. Cellular mechanisms of TGF-beta action. J Invest Dermatol 1990, 94:33S-40S.
108. Oca P., Zaka R., Dion A.S., Freeman T.A., Williams C.J. Phosphate and calcium are required for TGFbeta-mediated stimulation of Ank expression and function during chondrogenesis. J Cell Physiol 2010, 224:540-548.
109. Nesti L.J., Caterson E.J., Li W.J., Chang R., McCann T.D., Hoek J.B., et al. TGF-Beta1 calcium signaling in osteoblasts. J Cell Biochem 2007, 101:348-359.
110. 2+ wave and enhances gene expression in human pulmonary fibroblast. Am J Respir Cell Mol Biol 2012.
111. Dolmetsch R.E., Xu K., Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998, 392:933-936.
112. 2+ spike frequency can optimize gene expression. Nature 1998, 392:936-941.
113. Janssen L.J., Farkas L., Rahman T., Kolb M.R. Atp stimulates Ca(2+)-waves and gene expression in cultured human pulmonary fibroblasts. Int J Biochem Cell Biol 2009, 41:2477-2484.
114. Stewart E.A., Floor A.E., Jain P., Nowak R.A. Increased expression of messenger Rna for collagen type I, collagen type Iii, and fibronectin in myometrium of pregnancy. Obstet Gynecol 1995, 86:417-422.
115. Varga J., Rosenbloom J., Jimenez S.A. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin Mrnas in normal human dermal fibroblasts. Biochem J 1987, 247:597-604.
116. Penttinen R.P., Kobayashi S., Bornstein P. Transforming growth factor beta increases Mrna for matrix proteins both in the presence and in the absence of changes in Mrna stability. Proc Natl Acad Sci U S A 1988, 85:1105-1108.
117. Schuliga M.J., See I., Ong S.C., Soon L., Camoretti-Mercado B., Harris T., et al. Fibrillar collagen clamps lung mesenchymal cells in a nonproliferative and noncontractile phenotype. Am J Respir Cell Mol Biol 2009, 41:731-741.
118. Nesti L.J., Caterson E.J., Wang M., Chang R., Chapovsky F., Hoek J.B., et al. TGF-Beta1 calcium signaling increases alpha5 integrin expression in osteoblasts. J Orthop Res 2002, 20:1042-1049.
119. Halayko A.J., Ghavami S. S100a8/A9: a mediator of severe asthma pathogenesis and morbidity?. Can J Physiol Pharmacol 2009, 87:743-755.
120. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998-15004.
121. Schmidt A.M., Stern D.M. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Front Biosci 2001, 6:D1151-D1160.
122. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000, 1498:99-111.
123. Yamagishi S., Matsui T., Nakamura K. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes. Curr Drug Targets 2007, 8:1138-1143.
124. He M., Kubo H., Ishizawa K., Hegab A.E., Yamamoto Y., Yamamoto H., et al. The role of the receptor for advanced glycation end-products in lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2007, 293:L1427-L1436.
125. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999, 97:889-901.
126. Li J.H., Wang W., Huang X.R., Oldfield M., Schmidt A.M., Cooper M.E., et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-Erk1/2 map kinase signaling pathway. Am J Pathol 2004, 164:1389-1397.
127. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001, 108:1853-1863.
128. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993, 143:1699-1712.
129. Hanford L.E., Fattman C.L., Shaefer L.M., Enghild J.J., Valnickova Z., Oury T.D. Regulation of receptor for advanced glycation end products during bleomycin-induced lung injury. Am J Respir Cell Mol Biol 2003, 29:S77-S81.
130. Englert J.M., Hanford L.E., Kaminski N., Tobolewski J.M., Tan R.J., Fattman C.L., et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008, 172:583-591.
131. Uchida T., Shirasawa M., Ware L.B., Kojima K., Hata Y., Makita K., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006, 173:1008-1015.
132. Buhling F., Ittenson A., Kaiser D., Tholert G., Hoffmann B., Reinhold D., et al. Mrp8/Mrp14, Cd11b and Hla-Dr expression of alveolar macrophages in pneumonia. Immunol Lett 2000, 71:185-190.
133. Hayashi N., Kido J., Kido R., Wada C., Kataoka M., Shinohara Y., et al. Regulation of calprotectin expression by interleukin-1alpha and transforming growth factor-beta in human gingival keratinocytes. J Periodontal Res 2007, 42:1-7.
134. Cheng Z., Kang Y., Wu Q.G., Dai L.L., Song Y.N., Xia J., et al. Levels of Hmgb1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease. Zhonghua Yi Xue Za Zhi 2011, 91:2981-2984.
135. Hou C., Zhao H., Liu L., Li W., Zhou X., Lv Y., et al. High mobility group protein B1 (Hmgb1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 2011, 17:807-815.
136. Watanabe T., Asai K., Fujimoto H., Tanaka H., Kanazawa H., Hirata K. Increased levels of Hmgb-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 2011, 105:519-525.
137. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. Hmg-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
138. Andersson U., Erlandsson-Harris H., Yang H., Tracey K.J. Hmgb1 as a DNA-binding cytokine. J Leukoc Biol 2002, 72:1084-1091.
139. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301.
140. Ferhani N., Letuve S., Kozhich A., Thibaudeau O., Grandsaigne M., Maret M., et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181:917-927.
141. Kanazawa H., Tochino Y., Asai K., Ichimaru Y., Watanabe T., Hirata K. Validity of Hmgb1 measurement in epithelial lining fluid in patients with Copd. Eur J Clin Invest 2011.
142. Ghavami S., Chitayat S., Hashemi M., Eshraghi M., Chazin W.J., Halayko A.J., et al. S100a8/A9: a janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol 2009, 625:73-83.
143. Han E.C., Cho S.B., Ahn K.J., Oh S.H., Kim J., Kim D.S., et al. Expression of pro-inflammatory protein S100a12 (En-RAGE) in Behcet's disease and its association with disease activity: a pilot study. Ann Dermatol 2011, 23:313-320.
144. Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., et al. Expression of the pro-inflammatory protein S100a12 (En-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003, 42:1383-1389.
145. Hofmann Bowman M.A., Heydemann A., Gawdzik J., Shilling R.A., Camoretti-Mercado B. Transgenic expression of human S100a12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation. Clin Exp Allergy 2011, 41:878-889.
146. Camoretti-Mercado B., Karrar E., Nunez L. Hofmann Bowman MA. S100a12 and the airway smooth muscle: beyond inflammation and constriction. J Aller Ther 2012, S1:007. 10.4172/2155-6121.S1-007.
147. Yin L.M., Li H.Y., Zhang Q.H., Xu Y.D., Wang Y., Jiang Y.L., et al. Effects of S100a9 in a rat model of asthma and in isolated tracheal spirals. Biochem Biophys Res Commun 2010, 398:547-552.
148. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
149. Klionsky D.J. The molecular machinery of autophagy: unanswered questions. J Cell Sci 2005, 118:7-18.
150. Majeski A.E., Dice J.F. Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 2004, 36:2435-2444.
151. Alavian S.M., Ande S.R., Coombs K.M., Yeganeh B., Davoodpour P., Hashemi M., et al. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J Viral Hepat 2011, 18:821-830.
152. Eskelinen E.L. Maturation of autophagic vacuoles in mammalian cells. Autophagy 2005, 1:1-10.
153. Ghavami S., Mutawe M.M., Schaafsma D., Yeganeh B., Unruh H., Klonisch T., et al. Geranylgeranyl transferase 1 modulates autophagy and apoptosis in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2012, 302:L420-L428.
154. Mizushima N., Klionsky D.J. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007, 27:19-40.
155. Mizushima N., Yamamoto A., Matsui M., Yoshimori T., Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004, 15:1101-1111.
156. Lum J.J., Bauer D.E., Kong M., Harris M.H., Li C., Lindsten T., et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005, 120:237-248.
157. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005, 25:1025-1040.
158. Periyasamy-Thandavan S., Jiang M., Wei Q., Smith R., Yin X.M., Dong Z. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 2008, 74:631-640.
159. Ghavami S., Mutawe M.M., Sharma P., Yeganeh B., McNeill K.D., Klonisch T., et al. Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for P53. PLoS One 2011, 6:e16523.
160. Ding Y, Kim JK, Kim SI, Na HJ, Jun SY, Lee SJ, et al. TGF-{Beta}1 protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem.285:37909-919.
161. Kiyono K., Suzuki H.I., Matsuyama H., Morishita Y., Komuro A., Kano M.R., et al. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 2009, 69:8844-8852.
162. Gajewska M., Gajkowska B., Motyl T. Apoptosis and autophagy induced by TGF-B1 in bovine mammary epithelial Bme-UV1 cells. J Physiol Pharmacol 2005, 56(Suppl. 3):143-157.
163. Koesters R, Kaissling B, Lehir M, Picard N, Theilig F, Gebhardt R, et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol. 177:632-43.
164. Lamparska-Przybysz M., Gajkowska B., Motyl T. Cathepsins and bid are involved in the molecular switch between apoptosis and autophagy in breast cancer Mcf-7 cells exposed to camptothecin. J Physiol Pharmacol 2005, 56(Suppl. 3):159-179.
165. Horvath I., Donnelly L.E., Kiss A., Kharitonov S.A., Lim S., Chung K.F., et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998, 158:1042-1046.
166. Szumiel I. Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res 2011, 45:253-265.
167. Chen Z.H., Kim H.P., Sciurba F.C., Lee S.J., Feghali-Bostwick C., Stolz D.B., et al. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 2008, 3:e3316.
168. Cserjesi P., Brown D., Ligon K.L., Lyons G.E., Copeland N.G., Gilbert D.J., et al. Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 1995, 121:1099-1110.
169. Kim H.P., Wang X., Chen Z.H., Lee S.J., Huang M.H., Wang Y., et al. Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1. Autophagy 2008, 4:887-895.
170. Monick M.M., Powers L.S., Walters K., Lovan N., Zhang M., Gerke A., et al. Identification of an autophagy defect in smokers' alveolar macrophages. J Immunol 2010, 185:5425-5435.
171. Schweitzer R., Chyung J.H., Murtaugh L.C., Brent A.E., Rosen V., Olson E.N., et al. Analysis of the tendon cell fate using scleraxis, a specific marker for tendons and ligaments. Development 2001, 128:3855-3866.
172. Brent A.E., Schweitzer R., Tabin C.J. A somitic compartment of tendon progenitors. Cell. 2003, 113:235-248.
173. Espira L., Lamoureux L., Jones S.C., Gerard R.D., Dixon I.M., Czubryt M.P. The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J Mol Cell Cardiol 2009, 47:188-195.
174. Muir T., Sadler-Riggleman I., Skinner M.K. Role of the basic helix-loop-helix transcription factor, scleraxis, in the regulation of sertoli cell function and differentiation. Mol Endocrinol 2005, 19:2164-2174.
175. Liu Y., Watanabe H., Nifuji A., Yamada Y., Olson E.N., Noda M. Overexpression of a single helix-loop-helix-type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma Ros17/2.8 cells. J Biol Chem 1997, 272:29880-29885.
176. Lincoln J., Alfieri C.M., Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn 2004, 230:239-250.
177. Lejard V., Brideau G., Blais F., Salingcarnboriboon R., Wagner G., Roehrl M.H., et al. Scleraxis and Nfatc regulate the expression of the pro-alpha1(I) collagen gene in tendon fibroblasts. J Biol Chem 2007, 282:17665-17675.
178. Murchison N.D., Price B.A., Conner D.A., Keene D.R., Olson E.N., Tabin C.J., et al. Regulation of tendon differentiation by scleraxis distinguishes force-transmitting tendons from muscle-anchoring tendons. Development 2007, 134:2697-2708.
179. Jeffery P.K. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38.
180. Howarth P.H., Knox A.J., Amrani Y., Tliba O., Panettieri R.A., Johnson M. Synthetic responses in airway smooth muscle. J Allergy Clin Immunol 2004, 114:S32-S50.
181. Black P.N., Young P.G., Skinner S.J. Response of airway smooth muscle cells to TGF-beta 1: effects on growth and synthesis of glycosaminoglycans. Am J Physiol 1996, 271:L910-L917.
182. Anthwal N., Chai Y., Tucker A.S. The role of transforming growth factor-beta signalling in the patterning of the proximal processes of the murine dentary. Dev Dyn 2008, 237:1604-1613.
183. Khan R., Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006, 118:10-24.
184. Bagchi R.A., Czubryt M.P. Scleraxis: a new regulator of Ecm formation. Genes and cardiovascular function 2011, Springer. B. Ostadal (Ed.).
185. Kung C.P., Budina A., Balaburski G., Bergenstock M.K., Murphy M. Autophagy in tumor suppression and cancer therapy. Crit Rev Eukaryot Gene Expr 2011, 21:71-100.
186. Glaumann H., Ahlberg J. Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity-formation of crinosomes. Exp Mol Pathol 1987, 47:346-362.
187. Dean T., Dewey A., Bara A., Lasserson T.J., Walters E.H. Chloroquine as a steroid sparing agent for asthma. Cochrane Database Syst Rev 2003, CD003275.